FTC

Article

FDA and FTC Urged to Bring Enforcement Proceedings Against Joseph Mercola for False COVID-19 Health Claims

CSPI to Testify on COVID Scams in Senate Commerce Committee Today
July 21, 2020

Resource

Letters re: Request for Enforcement Regarding False COVID-19 Claims by Mercola Group

July 20, 2020
Article

CSPI Urges Federal Enforcement Action Against Supplement Manufacturers Making Illegal Antiviral Claims

Investigation Finds 46 Such Products on Amazon
June 4, 2020

Resource

CSPI Letters re: Antiviral Claims by Supplement Manufacturers

June 3, 2020
Article

Manufacturers of “Fertility” Supplements Selling False Hope

CSPI Asks the FDA and FTC to Take Enforcement Action
November 15, 2019
Three brands of "fertility support" supplements

Resource

Letter to FTC re: Supplements Marketed as Women's Fertility Aids

November 15, 2019
Three brands of "fertility support" supplements
Article

CSPI Asks Federal Trade Commission to Take Enforcement Action Against Relief Factor, Maker of Pain Pills Endorsed by Sebastian Gorka

FTC Considers Similar Endorsements by Non-Medical “Doctors” Deceptive
September 12, 2019
Article

FDA, FTC Warn Companies Marketing Supplements as Opioid Addiction Withdrawal Aids

Warning Letters Follow CSPI Investigation and Request for Enforcement Action
January 24, 2018

Resource

FDA Response to CSPI Letter

January 24, 2018

Resource

Letter to FTC Re: Supplements Marketed as Opioid Withdrawal Aids

December 8, 2017